BIOTRONIK, Charité and GHCF launch digital cardiology partnership
apopescu@pmlive.com | May 28, 2026 | News story | | Biotronik, Cardiology
BIOTRONIK, Charité – Universitätsmedizin Berlin and the German Heart Center Foundation (GHCF) have announced a partnership focused on advancing digital cardiology and connected health technology.
The collaboration will combine clinical expertise from Deutsches Herzzentrum der Charité (DHZC) with BIOTRONIK’s experience in implantable cardiac devices, artificial intelligence (AI), telemonitoring and connected health technologies.
The organisations said the partnership will support development of AI-driven tools, simulation technologies and device-based therapies for conditions including heart rhythm disorders and heart failure.
An endowed professorship for Digital and Translational Cardiology will also be established at Charité with support from BIOTRONIK and the Foundation. The initiative aims to attract international researchers and strengthen translational research in cardiovascular medicine.
Dr Volker Lang, Senior Vice President Research & Development at BIOTRONIK, said digital and predictive approaches were expected to play an increasing role in future cardiovascular care.
He added: “The future of cardiovascular care is digital, connected, and predictive… By integrating advanced AI, telemonitoring and implantable technologies with clinical research, we are transforming heart care and enabling better outcomes for patients worldwide.”
Professor Heyo K Kroemer, Chairman of the Board of Charité, said the partnership aimed to support innovation while also helping train future specialists in digital medicine.
“This strategic partnership demonstrates how academic medicine and industry research can work together to pave the way for data-driven cardiology,” Kroemer explained.
Heart failure and cardiac rhythm disorders remain major causes of hospitalisation and mortality globally, with growing interest in technologies capable of improving remote monitoring, earlier intervention and personalised treatment.
Professor Gerhard Hindricks, Interim Head of the Department of Cardiology, Angiology and Intensive Care Medicine at DHZC, said the partnership could help accelerate translation of scientific advances into clinical practice.
